Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2024
Medifast (NYSE: MED), the health and wellness company behind the OPTAVIA® lifestyle solution, has announced it will release its second quarter 2024 financial results on Monday, August 5, 2024, after market close. The company will host a conference call at 4:30 p.m. ET on the same day to discuss the results, featuring Dan Chard, Chairman and CEO, and Jim Maloney, CFO.
The call will be broadcast live on Medifast's Investor Relations website and archived until November 5, 2024. Listeners can join via telephone by dialing (201) 389-0879. A telephonic playback will be available from 8:30 p.m. ET, August 5, through August 12, 2024, accessible by dialing (412) 317-6671 with access code 13747501.
Medifast (NYSE: MED), l'azienda di salute e benessere dietro la soluzione di stile di vita OPTAVIA®, ha annunciato che rilascerà i suoi risultati finanziari del secondo trimestre 2024 il lunedì 5 agosto 2024, dopo la chiusura del mercato. L'azienda ospiterà una conference call alle 16:30 ET dello stesso giorno per discutere i risultati, con la partecipazione di Dan Chard, Presidente e CEO, e Jim Maloney, CFO.
La chiamata sarà trasmessa in diretta sul sito web delle Relazioni con gli Investitori di Medifast e sarà archiviata fino al 5 novembre 2024. Gli ascoltatori possono partecipare telefonicamente componendo il numero (201) 389-0879. Una registrazione telefonica sarà disponibile dalle 20:30 ET, 5 agosto, fino al 12 agosto 2024, accessibile componendo il numero (412) 317-6671 con il codice di accesso 13747501.
Medifast (NYSE: MED), la empresa de salud y bienestar detrás de la solución de estilo de vida OPTAVIA®, ha anunciado que publicará sus resultados financieros del segundo trimestre de 2024 el lunes 5 de agosto de 2024, después del cierre del mercado. La compañía realizará una llamada de conferencia a las 4:30 p.m. ET el mismo día para discutir los resultados, contando con la participación de Dan Chard, Presidente y CEO, y Jim Maloney, CFO.
La llamada se transmitirá en vivo en el sitio web de Relaciones con Inversionistas de Medifast y se archivará hasta el 5 de noviembre de 2024. Los oyentes pueden unirse por teléfono marcando el (201) 389-0879. Una grabación telefónica estará disponible desde las 8:30 p.m. ET, el 5 de agosto, hasta el 12 de agosto de 2024, accesible marcando el (412) 317-6671 con el código de acceso 13747501.
메디패스트 (NYSE: MED)는 OPTAVIA® 라이프스타일 솔루션을 제공하는 건강 및 웰니스 기업으로, 2024년 2분기 재무 결과를 2024년 8월 5일 월요일 시장 종료 후 발표할 것이라고 발표했습니다. 회사는 같은 날 오후 4:30 ET에 재무 결과를 논의하기 위한 컨퍼런스 콜을 주최할 예정이며, Dan Chard 회장 겸 CEO와 Jim Maloney CFO가 참석할 것입니다.
이 통화는 메디패스트의 투자자 관계 웹사이트에서 실시간으로 방송되며 2024년 11월 5일까지 아카이브됩니다. 청취자들은 (201) 389-0879로 전화하여 참여할 수 있습니다. 전화 재생은 8월 5일 오후 8:30 ET부터 2024년 8월 12일까지 사용 가능하며, (412) 317-6671로 전화하고 액세스 코드 13747501을 입력하면 됩니다.
Medifast (NYSE: MED), l'entreprise de santé et de bien-être derrière la solution de style de vie OPTAVIA®, a annoncé qu'elle publiera ses résultats financiers pour le deuxième trimestre 2024 le lundi 5 août 2024, après la fermeture du marché. L'entreprise organisera une conférence téléphonique à 16h30 ET le même jour pour discuter des résultats, avec la participation de Dan Chard, Président et CEO, et Jim Maloney, CFO.
La conférence sera diffusée en direct sur le site Web des Relations Investisseurs de Medifast et sera archivée jusqu'au 5 novembre 2024. Les auditeurs peuvent rejoindre par téléphone en composant le (201) 389-0879. Une rediffusion téléphonique sera disponible à partir de 20h30 ET, le 5 août, jusqu'au 12 août 2024, accessible en composant le (412) 317-6671 avec le code d'accès 13747501.
Medifast (NYSE: MED), das Unternehmen für Gesundheit und Wellness hinter der OPTAVIA®-Lebensstil-Lösung, hat angekündigt, dass es seine Finanzergebnisse für das zweite Quartal 2024 am Montag, den 5. August 2024, nach Marktschluss veröffentlichen wird. Das Unternehmen wird am selben Tag um 16:30 Uhr ET eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen, an der Dan Chard, Vorsitzender und CEO, sowie Jim Maloney, CFO, teilnehmen werden.
Die Konferenz wird live auf der Investor Relations-Website von Medifast übertragen und bis zum 5. November 2024 archiviert. Zuhörer können telefonisch unter (201) 389-0879 teilnehmen. Eine telefonische Wiedergabe wird vom 5. August, 20:30 Uhr ET, bis zum 12. August 2024 verfügbar sein, erreichbar unter (412) 317-6671 mit dem Zugangscode 13747501.
- None.
- None.
The conference call is scheduled to begin at 4:30 p.m. ET on August 5, 2024. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast's website at www.MedifastInc.com or directly at https://viavid.webcasts.com/starthere.jsp?ei=1678505&tp_key=f8865fb1bd and will be archived online and available through November 5, 2024. To join via telephone, listeners may dial (201) 389-0879.
A telephonic playback will be available from 8:30 p.m. ET, August 5, 2024, through August 12, 2024. Participants can dial (412) 317-6671 and enter access code 13747501 to hear the playback.
About Medifast®
Medifast (NYSE: MED) is the health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA®, which provides people with a simple yet comprehensive approach to address obesity and support a healthy lifestyle. OPTAVIA's holistic solution includes lifestyle plans with clinically proven health benefits, scientifically developed products, and a framework for habit creation – all reinforced by independent coach support for customers on their weight loss journeys. Through its collaboration with national virtual primary care provider LifeMD® (Nasdaq: LFMD) and its affiliated medical group, the holistic solution now includes access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature™. Visit the OPTAVIA and Medifast websites for more information and follow Medifast on X and LinkedIn.
MED-F
View source version on businesswire.com: https://www.businesswire.com/news/home/20240722880321/en/
Investor Contact:
Medifast, Inc.
Steven Zenker
InvestorRelations@medifastinc.com
(443) 379-5256
Source: Medifast, Inc.
FAQ
When will Medifast (MED) release its Q2 2024 financial results?
What time is Medifast's (MED) Q2 2024 earnings conference call?
Who will be participating in Medifast's (MED) Q2 2024 earnings call?
How can I listen to Medifast's (MED) Q2 2024 earnings call?
Until when will Medifast's (MED) Q2 2024 earnings call recording be available?
